logo
Most stocks fall as hopes weaken for a September cut to interest rates

Most stocks fall as hopes weaken for a September cut to interest rates

Most U.S. stocks slipped on Wednesday after doubts rose on Wall Street about whether the Federal Reserve will deliver economy-juicing cuts to interest rates by September.
The S&P 500 edged down by 0.1%, coming off its first loss after setting all-time highs for six successive days. The Dow Jones Industrial Average dropped 171 points, or 0.4%, and the Nasdaq composite rose 0.1%.
Stocks felt pressure from rising Treasury yields in the bond market after the Federal Reserve voted to hold its main interest rate steady. The move may upset President Donald Trump, who has been angrily lobbying for lower interest rates, but it was widely expected on Wall Street.
What may have surprised investors more was Fed Chair Jerome Powell's pushing back on expectations that the Fed could cut rates at its next meeting in September. Besides Trump, two members of the Fed's committee have also been calling for lower rates to ease the pressure on the economy, and they dissented in Wednesday's vote.
But Powell would not commit to a September cut in rates, pointing to how inflation remains above the Fed's 2% target, while the job market still looks to be 'in balance.'
A cut in rates would give the job market and overall economy a boost, but it could also risk fueling inflation when Trump's tariffs may be set to raise prices for U.S. consumers. The Fed's job is to keep both the job market and inflation in a good place.
Trump on Wednesday announced a 25% tariff on imports coming from India, along with an additional tax because of India's purchases of Russian oil, beginning on Aug. 1. That's when stiff tariffs Trump has proposed for many other countries are also scheduled to kick in, unless they reach trade deals that lower the rates.
'The economy is in good shape, but it's in an unusual situation,' Powell said.
He also said that the Fed will receive two months' worth of data on inflation, the job market and other economic indicators before it meets again to vote on rates in September. That could give the Fed more confidence that the risk of high inflation is no longer bigger than the risk of a weak job market, a combination that would prod officials toward lowering rates.
Powell's comments drove traders to pare back bets on a cut in September. They now see just a 45% chance of that, down from a nearly 65% probability a day earlier, according to data from CME Group.
The yield on the two-year U.S. Treasury note rose to 3.93% from 3.86% late Tuesday. It tends to closely follow expectations for what the Fed will do with its overnight interest rate.
The 10-year Treasury, which also takes into account longer-term expectations for the economy and inflation, rose to 4.36% from 4.34%.
A report earlier in the morning suggested the U.S. economy's growth was much stronger during the spring than economists expected. But underlying trends beneath the surface may be more discouraging.
'Cutting through the noise of the swings in imports, the economy is still chugging along, but it is showing signs of sputtering,' said Brian Jacobsen, chief economist at Annex Wealth Management.
On Wall Street, Humana rose 12.4% after the insurer and health care giant reported stronger results for the spring than expected. It also raised its forecasts for profit and revenue over the full year.
Video-game maker Electronic Arts climbed 5.7% after likewise topping Wall Street's expectations.
Companies are under pressure to deliver solid profit growth. They need to in order to justify the big jumps in their stock prices during recent months, which has caused some critics to say the broad U.S. stock market looks too expensive.
Trane Technologies, whose stock came into the day with a 27.5% gain for the year so far, tumbled even though it reported a stronger-than-expected profit for the latest quarter. The heating, ventilation and air conditioning company's revenue came up short of analysts' estimates, as did its forecast for profit in the current quarter. It dropped 8.4%.
Freeport-McMoRan, a copper producer with mines around the world, tumbled 9.5% after Trump signed an executive order to tax imports of copper at 50%.
Starbucks slipped 0.2% after reporting a weaker profit than analysts expected as it tries to turn around its operations. The company is hoping to boost its performance through improved store operations and new products, including a cold foam protein drink.
All told, the S&P 500 slipped 7.96 points to 6,362.90. The Dow Jones Industrial Average dropped 171.71 to 44,461.28, and the Nasdaq composite rose 31.38 to 21,129.67.
In stock markets abroad, indexes were mixed across Europe and Asia. Hong Kong's Hang Seng fell 1.4%, and South Korea's Kospi rose 0.7% for two of the bigger moves.
Choe writes for the Associated Press.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Regeneron shares edge higher as second quarter earnings surpass estimates
Regeneron shares edge higher as second quarter earnings surpass estimates

Yahoo

timea minute ago

  • Yahoo

Regeneron shares edge higher as second quarter earnings surpass estimates

-- Regeneron Pharmaceuticals, Inc. reported second-quarter earnings that significantly exceeded analyst expectations, with adjusted earnings per share reaching $12.89 compared to the $8.43 consensus estimate. Revenue also beat forecasts, coming in at $3.68 billion versus the expected $3.28 billion. The biopharmaceutical company's total revenue increased 4% YoY, driven by strong performance across several key products. Dupixent global net sales, recorded by Sanofi (NASDAQ:SNY), grew 22% to $4.34 billion, while EYLEA HD U.S. net sales jumped 29% to $393 million. However, combined EYLEA HD and EYLEA U.S. net sales decreased 25% to $1.15 billion. The stock is up 0.3% following the results. "Regeneron (NASDAQ:REGN) had a strong quarter, marked by significant growth in U.S. sales of EYLEA HD and global sales of Dupixent and Libtayo along with multiple regulatory approvals," said Leonard Schleifer, Chief Executive Officer of Regeneron. The company reported several regulatory achievements during the quarter, including FDA approval for Lynozyfic for relapsed or refractory multiple myeloma and Dupixent approvals for bullous pemphigoid and chronic spontaneous urticaria. The FDA also accepted for priority review Libtayo's application for adjuvant cutaneous squamous cell carcinoma. Regeneron updated its financial guidance for 2025, adjusting its R&D and SG&A expense projections. The company now expects non-GAAP R&D expenses of $5.1-$5.2 billion and non-GAAP SG&A expenses of $2.45-$2.55 billion. During the quarter, Regeneron returned over $2.3 billion to shareholders through share repurchases and dividends. The company's board declared a cash dividend of $0.88 per share, payable on September 3, 2025. Related articles Regeneron shares edge higher as second quarter earnings surpass estimates These Under-the-Radar Stocks Offer Better Risk-Reward Ratio Than Nvidia Apollo economist warns: AI bubble now bigger than 1990s tech mania Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Moderna lowers top end of revenue guidance as vaccine group targets cost cuts
Moderna lowers top end of revenue guidance as vaccine group targets cost cuts

Yahoo

timea minute ago

  • Yahoo

Moderna lowers top end of revenue guidance as vaccine group targets cost cuts

- Moderna has lowered the top end of its full-year revenue forecast, citing a delay in the timing of deliveries of its COVID-19 jab to the United Kingdom, presenting a fresh setback for a company already aiming to slash expenses and boost recently tepid demand. The vaccine maker said it now anticipates that annual revenue will come in at $1.5 billion to $2.2 billion, compared to a prior estimate of $1.5 billion to $2.5 billion, flagging the impact of change in the expected date of the shipments to the first quarter of its next fiscal year from the second half of 2025. Bloomberg consensus estimates had called for guidance of $2.07 billion. Shares of Moderna (NASDAQ:MRNA) sank in premarket U.S. trading. The stock has slumped by more than 29% so far this year. Friday's announcement comes after Moderna announced a sweeping headcount reduction earlier this week that will see it slash around 10% of its global staff and have less than 5,000 employees by the end of the year. Moderna has been pushing to bring down costs as it grapples with flagging sales of its once mega-popular COVID-19 vaccines. Such cost-cutting efforts helped to bring overall operating expenses for the second quarter down by 35% versus a year ago to $1.05 billion. Bancel said Moderna now expects full-year operating expenses to be between $5.9 billion to $6.1 billion, an improvement of approximately $400 million from its prior outlook. Quarterly revenue, meanwhile, dropped by 41% to $142 million, but topped expectations for $108.5 million. Moderna's loss per share of $2.13 for the period was also less than analysts had anticipated. Related articles Moderna lowers top end of revenue guidance as vaccine group targets cost cuts Risks Rising? Smart Money Dodged 46%+ Drawdowns on These High-Flying Names If Powell goes, does Fed trust go with him? Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Stock market today: Dow, S&P 500, Nasdaq futures slump after Trump's sweeping tariffs, Amazon's earnings flub
Stock market today: Dow, S&P 500, Nasdaq futures slump after Trump's sweeping tariffs, Amazon's earnings flub

Yahoo

timea minute ago

  • Yahoo

Stock market today: Dow, S&P 500, Nasdaq futures slump after Trump's sweeping tariffs, Amazon's earnings flub

US stock futures sank on Friday after President Trump officially hit virtually every US trading partner with sweeping tariff hikes, pushing ahead with his plan to remake the global trade order. Dow Jones Industrial Average futures (YM=F) dropped 0.9%, while those on the S&P 500 (ES=F) fell around 1%. Contracts on the tech-heavy Nasdaq 100 (NQ=F) also sank around 1%, on the heels of a losing day for the major US gauges. The retreat in stocks came as markets assessed the reshaped US trade landscape after President Trump on Thursday hit dozens of countries — including crucial partners Taiwan and India — with steep new tariffs. His executive order formally authorized a hike in levies on Canada to 35%, to go into effect on Friday. Most of the other "reciprocal" rates range from 15% to 40% (though the baseline remains 10%) and will be implemented in seven days. The White House also confirmed details of trade agreements negotiated by some trading partners before the Aug 1. deadline for "Liberation Day" tariffs to hit. But Trump said the implementation of the hiked levies will be pushed back by seven days, opening up scope for more talks. Read more: The latest on Trump's tariffs Also dragging on spirits was disappointment over Amazon's (AMZN) earnings released late Thursday. The performance of its AWS cloud unit failed to live up to lofty expectations set by rivals Google (GOOG, GOOGL) and Microsoft (MSFT), sending its shares down over 8%. But Apple (AAPL) stock rose after its results beat expectations, boosted by surprisingly strong iPhone sales. A blockbuster week on Wall Street is set to end not just with trade turmoil but also with the July jobs report, which is expected to show hiring slowed while unemployment ticked higher. The key indicator of US economic health will be closely watched by the Federal Reserve, whose preferred inflation gauge on Thursday showed signs of increasing price pressures. Big Tech's AI and core businesses are blurring together This week, investors heard quarterly updates from Apple (AAPL), Amazon (AMZN), Microsoft (MSFT), and Meta (META). And in the midst of strong quarterly financial results from Big Tech, a new paradigm is emerging, Yahoo Finance's Hamza Shaban wrote in today's Morning Brief. Hamza writes: Read more here. Chevron beats Wall Street profit estimates with record production Chevron (CVX) beat analyst estimates on Friday for second-quarter profit as record oil and gas production and lower capital expenditure helped the US oil producer boost earnings despite weaker crude prices. Chevron shares were flat in premarket trading. Reuters reports: Read more here. Exxon beats profit estimates with higher production despite weak oil prices Shares in Exxon Mobil (XOM) rose more than 1% before the bell on Friday after the company beat Wall Street estimate for second-quarter profit as higher oil and gas production helped the top US oil producer overcome lower crude prices. Reuters reports: Read more here. Eyes on Figma, day two After a sizzling 250% surge on Thursday IPO day, Figma (FIG) is up another 8% pre-market. You are watching the forming of a stock bubble in real time here! I encourage you to read up on the company's not so impressive financials this weekend. US stock losses pick up pace after Trump's tariff blitz The retreat in US stock futures accelerated on Friday morning as Wall Street weighed the likely fallout from President Trump's trade war. The broad benchmark S&P 500 (ES=F) was down 1% with four hours to go before the market open, having held not far below the flat line in earlier overnight trade. Futures on The Dow Jones Industrial Average (YM=F) sank 0.9%, while contracts on the tech-heavy Nasdaq 100 (NQ=F) dived 1.1%. Markets are assessing the reshaped US trade landscape after President Trump on Thursday hit dozens of countries — including crucial partners Taiwan and India — with steep new tariffs. July jobs report on deck: What to watch The countdown is on for the release of the US nonfarm-payrolls reading for July, the final piece in a string of top-tier data this week. Yahoo Finance's Josh Schafer lays out what's in store: Read more here. Asian markets slide as tariffs rock global boat Asian markets fell overnight Thursday following the White House's announcement that Trump's sweeping tariffs on many of America's largest trading partners will be implemented in varying degrees of severity. Reuters reports: Read more here. Big Tech's AI and core businesses are blurring together This week, investors heard quarterly updates from Apple (AAPL), Amazon (AMZN), Microsoft (MSFT), and Meta (META). And in the midst of strong quarterly financial results from Big Tech, a new paradigm is emerging, Yahoo Finance's Hamza Shaban wrote in today's Morning Brief. Hamza writes: Read more here. This week, investors heard quarterly updates from Apple (AAPL), Amazon (AMZN), Microsoft (MSFT), and Meta (META). And in the midst of strong quarterly financial results from Big Tech, a new paradigm is emerging, Yahoo Finance's Hamza Shaban wrote in today's Morning Brief. Hamza writes: Read more here. Chevron beats Wall Street profit estimates with record production Chevron (CVX) beat analyst estimates on Friday for second-quarter profit as record oil and gas production and lower capital expenditure helped the US oil producer boost earnings despite weaker crude prices. Chevron shares were flat in premarket trading. Reuters reports: Read more here. Chevron (CVX) beat analyst estimates on Friday for second-quarter profit as record oil and gas production and lower capital expenditure helped the US oil producer boost earnings despite weaker crude prices. Chevron shares were flat in premarket trading. Reuters reports: Read more here. Exxon beats profit estimates with higher production despite weak oil prices Shares in Exxon Mobil (XOM) rose more than 1% before the bell on Friday after the company beat Wall Street estimate for second-quarter profit as higher oil and gas production helped the top US oil producer overcome lower crude prices. Reuters reports: Read more here. Shares in Exxon Mobil (XOM) rose more than 1% before the bell on Friday after the company beat Wall Street estimate for second-quarter profit as higher oil and gas production helped the top US oil producer overcome lower crude prices. Reuters reports: Read more here. Eyes on Figma, day two After a sizzling 250% surge on Thursday IPO day, Figma (FIG) is up another 8% pre-market. You are watching the forming of a stock bubble in real time here! I encourage you to read up on the company's not so impressive financials this weekend. After a sizzling 250% surge on Thursday IPO day, Figma (FIG) is up another 8% pre-market. You are watching the forming of a stock bubble in real time here! I encourage you to read up on the company's not so impressive financials this weekend. US stock losses pick up pace after Trump's tariff blitz The retreat in US stock futures accelerated on Friday morning as Wall Street weighed the likely fallout from President Trump's trade war. The broad benchmark S&P 500 (ES=F) was down 1% with four hours to go before the market open, having held not far below the flat line in earlier overnight trade. Futures on The Dow Jones Industrial Average (YM=F) sank 0.9%, while contracts on the tech-heavy Nasdaq 100 (NQ=F) dived 1.1%. Markets are assessing the reshaped US trade landscape after President Trump on Thursday hit dozens of countries — including crucial partners Taiwan and India — with steep new tariffs. The retreat in US stock futures accelerated on Friday morning as Wall Street weighed the likely fallout from President Trump's trade war. The broad benchmark S&P 500 (ES=F) was down 1% with four hours to go before the market open, having held not far below the flat line in earlier overnight trade. Futures on The Dow Jones Industrial Average (YM=F) sank 0.9%, while contracts on the tech-heavy Nasdaq 100 (NQ=F) dived 1.1%. Markets are assessing the reshaped US trade landscape after President Trump on Thursday hit dozens of countries — including crucial partners Taiwan and India — with steep new tariffs. July jobs report on deck: What to watch The countdown is on for the release of the US nonfarm-payrolls reading for July, the final piece in a string of top-tier data this week. Yahoo Finance's Josh Schafer lays out what's in store: Read more here. The countdown is on for the release of the US nonfarm-payrolls reading for July, the final piece in a string of top-tier data this week. Yahoo Finance's Josh Schafer lays out what's in store: Read more here. Asian markets slide as tariffs rock global boat Asian markets fell overnight Thursday following the White House's announcement that Trump's sweeping tariffs on many of America's largest trading partners will be implemented in varying degrees of severity. Reuters reports: Read more here. Asian markets fell overnight Thursday following the White House's announcement that Trump's sweeping tariffs on many of America's largest trading partners will be implemented in varying degrees of severity. Reuters reports: Read more here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store